Nov 17, 2020
Suffering in Silence: Two-Thirds of Older Adults Say They Won’t Treat Their Depression
Products
Nov 16, 2020
Myriad Genetics Announces Global Expansion of Myriad myChoice® Tumor Testing in Europe and China
Pipeline
Nov 11, 2020
New Data Show Importance of Vectra® Testing and Biomarkers in Predicting Risk for Cardiovascular Events in Patients with Rheumatoid Arthritis
Pipeline
Nov 09, 2020
Myriad Genetics Delivers 56% Sequential Increase in Quarterly Revenue; Test Volumes Reach 90% of Pre-COVID-19 Level at End of Quarter
Financial
Nov 04, 2020
Myriad Genetics to Announce Quarterly Financial Results on November 9, 2020
Financial
Oct 16, 2020
German Federal Joint Committee (G-BA) Issues Nationwide Reimbursement Decision for EndoPredict® Breast Cancer Prognostic Test
Pipeline
Oct 15, 2020
Myriad Genetics Files Fiscal Year 2020 Proxy Statement, Implements Corporate Governance Changes In Support of Stakeholder Interests
Corporate
Sep 10, 2020
Myriad Genetics Expands Board of Directors with New Member
Corporate
Aug 21, 2020
American Society of Clinical Oncology Exclusively Cites myChoice® CDx in New Recommendations for Patients with Advanced Ovarian Cancer
Pipeline
Aug 14, 2020
Myriad Genetics Announces Inducement Awards
Corporate
Aug 13, 2020
Myriad Genetics Appoints Paul J. Diaz as President and Chief Executive Officer and a Member of the Board of Directors
Corporate
Aug 13, 2020
Myriad Genetics Reports Fiscal Fourth-Quarter 2020 Financial Results
Financial
Aug 10, 2020
New Study Shows Screening Based on Self-Reported Ethnicity Fails to Identify Significant Percentage of Pregnancies Affected by Serious Genetic Conditions
Pipeline
Aug 06, 2020
Myriad to Announce Fiscal Fourth-Quarter and Full Fiscal Year 2020 Financial Results on August 13, 2020
Corporate
Jul 31, 2020
Medicare Expands Coverage for BRACAnalysis® CDx in Prostate Cancer
Pipeline